Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 19, 2022 08:00 ET | Source: Nemaura Medical, Inc

Nemaura Medical to Present at the H.C. Wainwright Global Hybrid Investment Conference

Loughborough, England, May 19, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
May 17, 2022 08:00 ET | Source: Nemaura Medical, Inc

MySugarWatch Continues Large-Scale Awareness Campaign Around Nemaura Medical’s sugarBEAT Non-Invasive Continuous Glucose Monitor Commencing Direct-to-Consumer Campaign in Daily Mail

Loughborough, England, May 17, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
May 03, 2022 08:00 ET | Source: Nemaura Medical, Inc

MySugarWatch Launches Physician-Focused Ads in MIMS As Part of Large-Scale Awareness Campaign Around Nemaura Medical’s sugarBEAT Non-Invasive Continuous Glucose Monitor

Loughborough, England, May 03, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
April 25, 2022 08:30 ET | Source: Nemaura Medical, Inc

Nemaura Medical to Present at the Planet MicroCap Showcase 2022

Loughborough, England, April 25, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
March 24, 2022 16:24 ET | Source: Nemaura Medical, Inc

Nemaura Medical to Present at the Maxim Group 2022 Virtual Growth Conference

Loughborough, England, March 24, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
February 28, 2022 08:00 ET | Source: Nemaura Medical, Inc

Nemaura Medical Wins Innovation Awards

Loughborough, England, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
February 14, 2022 08:00 ET | Source: Nemaura Medical, Inc

Nemaura Medical Announces Fiscal Third Quarter 2022 Financial Results and Provides Business Update

Loughborough, England, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
January 13, 2022 08:30 ET | Source: Nemaura Medical, Inc

Nemaura Medical Launches Metabolic Health Program for Employers and Insurers

Launch into commercial markets offers opportunities for faster and wider adoption of Miboko program Loughborough, England, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)...
January 10, 2022 08:00 ET | Source: Nemaura Medical, Inc

Nemaura Medical Appoints Dr. Arash Ghadar as Chief Operating Officer

Loughborough, England, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
January 07, 2022 08:00 ET | Source: Nemaura Medical, Inc

Nemaura Medical to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference

Loughborough, England, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right